Literature DB >> 1381302

Hepatitis C: a possible etiology for cryoglobulinaemia type II.

A Pechère-Bertschi1, L Perrin, P de Saussure, J J Widmann, E Giostra, J A Schifferli.   

Abstract

Out of 15 successive patients with mixed essential cryoglobulinaemia type II (monoclonal IgM kappa/IgG), 13 had serological evidence for hepatitis C infection as shown by specific enzyme immunoassays and immunoblot. RNA was purified from the serum of seven patients and hepatitis C sequences were identified in five following reverse transcription and DNA amplification. The liver histology showed chronic active hepatitis with or without cirrhosis in the 12 patients with hepatitis C who had a liver biopsy. The two patients without serological evidence of hepatitis C suffered from haematological malignancies. Hepatitis C may be a major etiological agent of cryoglobulinaemia type II.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381302      PMCID: PMC1554477          DOI: 10.1111/j.1365-2249.1992.tb06973.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia.

Authors:  C Vitali; M Sciuto; R Neri; F Greco; A K Mavridis; A G Tsioufas; E V Tsianos
Journal:  Clin Exp Rheumatol       Date:  1992 Jan-Feb       Impact factor: 4.473

2.  Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia.

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; P V Fosella; G Pasero; S Bombardieri
Journal:  Arthritis Rheum       Date:  1991-12

3.  Liver involvement in the syndrome of mixed cryoglobulinemia.

Authors:  Y Levo; P D Gorevic; H J Kassab; H Tobias; E C Franklin
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

Review 4.  Reappraisal of the clinical expression of mixed cryoglobulinemia.

Authors:  G Montagnino
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Correlation of hepatocyte HBsAg expression with virus replication and liver pathology.

Authors:  H C Hsu; M Y Lai; I J Su; D S Chen; M H Chang; P M Yang; C Y Wu; H C Hsieh
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

6.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

7.  Treatment of idiopathic mixed cryoglobulinemia with alpha interferon.

Authors:  L Bonomo; M Casato; A Afeltra; D Caccavo
Journal:  Am J Med       Date:  1987-10       Impact factor: 4.965

8.  Persistent Epstein-Barr virus infection in patients with type II essential mixed cryoglobulinemia.

Authors:  G F Fiorini; R A Sinico; C Winearls; P Custode; C De Giuli-Morghen; G D'Amico
Journal:  Clin Immunol Immunopathol       Date:  1988-06

9.  Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 10.  Clearance of cryoglobulins in man.

Authors:  Y C Ng; J A Schifferli
Journal:  Springer Semin Immunopathol       Date:  1988
View more
  13 in total

Review 1.  Cryoglobulins in chronic hepatitis C virus infection.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 2.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; M Montrone; F A Tucci; L Nisi; F Dammacco
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Cryoglobulins are not essential.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

5.  Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia.

Authors:  A Gabrielli; A Manzin; M Candela; M L Caniglia; S Paolucci; M G Danieli; M Clementi
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

Authors:  K Ueda; H Nakajima; T Nakagawa; A Shimizu
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?

Authors:  E Apartis; J M Léger; L Musset; M Gugenheim; P Cacoub; O Lyon-Caen; C Pierrot-Deseilligny; J J Hauw; P Bouche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

8.  IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.

Authors:  A L'Abbate; S Cutrupi; M Rognetta; C Fabiano; A Craxi
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

9.  Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.

Authors:  Robin A Herlands; Jacqueline William; Uri Hershberg; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

10.  Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus.

Authors:  E Petrelli; A Manzin; S Paolucci; A Cioppi; M Brugia; P Muretto; M Clementi
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.